Ondansetron and Blood Coagulation

Last updated: March 13, 2023
Sponsor: Seoul National University Bundang Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Blood Clots

Treatment

N/A

Clinical Study ID

NCT04499274
B-2008/631-305
  • Ages 20-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Ondansetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of ondansetron. The investigators therefore will perform the present study to measure the effect of ondansestron on the blood coagulation pathway according to the drug concentration level using a thromboelastography test.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy vonlunteers
  • Age: 20 to 65 years
  • Body weight > 50 kg
  • Volunteers who provided informed consent

Exclusion

Exclusion Criteria:

  • Hematologic disease
  • Anticoagulant medication

Study Design

Total Participants: 12
Study Start date:
September 16, 2020
Estimated Completion Date:
December 15, 2023

Connect with a study center

  • Seoul National Univ. Bundang Hospital

    Seongnam, Gyeonggi 463-707
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.